These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 33666647

  • 1. Group 2 innate lymphoid cells support hematopoietic recovery under stress conditions.
    Sudo T, Motomura Y, Okuzaki D, Hasegawa T, Yokota T, Kikuta J, Ao T, Mizuno H, Matsui T, Motooka D, Yoshizawa R, Nagasawa T, Kanakura Y, Moro K, Ishii M.
    J Exp Med; 2021 May 03; 218(5):. PubMed ID: 33666647
    [Abstract] [Full Text] [Related]

  • 2. Group 2 innate lymphoid cells in bone marrow regulate osteoclastogenesis in a reciprocal manner via RANKL, GM-CSF and IL-13.
    Momiuchi Y, Motomura Y, Suga E, Mizuno H, Kikuta J, Morimoto A, Mochizuki M, Otaki N, Ishii M, Moro K.
    Int Immunol; 2021 Oct 29; 33(11):573-585. PubMed ID: 34498703
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.
    Sudo T, Yokota T, Okuzaki D, Ueda T, Ichii M, Ishibashi T, Isono T, Habuchi Y, Oritani K, Kanakura Y.
    PLoS One; 2016 Oct 29; 11(4):e0154189. PubMed ID: 27111450
    [Abstract] [Full Text] [Related]

  • 6. The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo.
    Quesniaux VF, Wehrli S, Steiner C, Joergensen J, Schuurman HJ, Herrman P, Schreier MH, Schuler W.
    Blood; 1994 Sep 01; 84(5):1543-52. PubMed ID: 7520778
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J.
    Blood; 1993 Apr 01; 81(7):1709-19. PubMed ID: 7681699
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
    Kriegler AB, Verschoor SM, Bernardo D, Bertoncello I.
    Exp Hematol; 1994 May 01; 22(5):432-40. PubMed ID: 7513652
    [Abstract] [Full Text] [Related]

  • 10. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.
    Aerts-Kaya F, Kilic E, Köse S, Aydin G, Cagnan I, Kuskonmaz B, Uckan-Cetinkaya D.
    Cytokine; 2021 Mar 01; 139():155407. PubMed ID: 33383380
    [Abstract] [Full Text] [Related]

  • 11. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO, Schneider JG, Moore MA.
    Exp Hematol; 1992 Mar 01; 20(3):339-49. PubMed ID: 1373685
    [Abstract] [Full Text] [Related]

  • 12. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G, Bueren JA, Maganto G, Tuduri P, Guerrero A, Pivel JP, Real A.
    Stem Cells; 1995 Mar 01; 13(2):175-85. PubMed ID: 7540471
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
    Keller JR, Jacobsen SE, Sill KT, Ellingsworth LR, Ruscetti FW.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7190-4. PubMed ID: 1831268
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
    Wang M, Subramanian M, Abramowicz S, Murphy AJ, Gonen A, Witztum J, Welch C, Tabas I, Westerterp M, Tall AR.
    Arterioscler Thromb Vasc Biol; 2014 May 15; 34(5):976-84. PubMed ID: 24651678
    [Abstract] [Full Text] [Related]

  • 17. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
    Moore MA, Warren DJ.
    Proc Natl Acad Sci U S A; 1987 Oct 15; 84(20):7134-8. PubMed ID: 3499607
    [Abstract] [Full Text] [Related]

  • 18. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K, McKenna HJ, Charrier K, Morrissey PJ, Williams DE, Lyman SD.
    Blood; 1997 Nov 01; 90(9):3781-8. PubMed ID: 9345066
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer.
    Danova M, Rosti V, Mazzini G, De Renzis MR, Locatelli F, Cazzola M, Riccardi A, Ascari E.
    Int J Cancer; 1995 Nov 27; 63(5):646-51. PubMed ID: 7591280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.